Inotropes or inodilators in Heart Failure with reduced Ejection Fraction (HFrEF): what to use, on whom, when and how? The therapeutic needs

Veil-Pekka Horjola looks at the clinical indications for inotropic agents detailing the main problem with these is hypoperfusion (hypotension, decreased renal function). He discussed cardiogenic shock – while the prognosis has slowly improved over the past few decades, mortality is still high.

 

ESC Heart Failure 2017 resources


Videos (20)
Login/ Register Maximise Minimise